α-Fetoprotein, free β-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome

This publication has 18 references indexed in Scilit:

• Reducing the Need for Amniocentesis in Women 35 Years of Age or Older with Serum Markers for Screening
  New England Journal of Medicine, 1994
• Low levels of amniotic fluid placental alkaline phosphatase in Down's syndrome
  BJOG: An International Journal of Obstetrics and Gynaecology, 1993
• Low maternal serum levels of pregnancy associated plasma protein A (PAPP‐A) in the first trimester in association with abnormal fetal karyotype
  BJOG: An International Journal of Obstetrics and Gynaecology, 1993
• Free Beta Human Choriogonadotropin in Down's Syndrome Screening: A Multicentre Study of its Role Compared with other Biochemical Markers
  Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1992
• Prenatal Screening for Down's Syndrome with Use of Maternal Serum Markers
  New England Journal of Medicine, 1992
• CA‐125 as a maternal serum marker for Down's syndrome in the first and second trimesters
  Prenatal Diagnosis, 1992
• Maternal serum Down syndrome screening: Free β-protein is a more effective marker than human chorionic gonadotropin
  American Journal of Obstetrics and Gynecology, 1990
• Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome
  BJOG: An International Journal of Obstetrics and Gynaecology, 1988
• Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities
  Prenatal Diagnosis, 1987
• MATERNAL SERUM ALPHA-FETOPROTEIN MEASUREMENT: A SCREENING TEST FOR DOWN SYNDROME
  The Lancet, 1984